CVE-2026-18073

CVE-2026-18073 is a medium-severity vulnerability in Ibm I with a CVSS 3.x base score of 4.4. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-78.

Key facts

Description

IBM i 7.6, 7.5, 7.4, and 7.3 could allow a local authenticated attacker to inject parameters into a CL command due to improper neutralization of special elements.

Frequently asked questions

What is CVE-2026-18073?
IBM i 7.6, 7.5, 7.4, and 7.3 could allow a local authenticated attacker to inject parameters into a CL command due to improper neutralization of special elements.
How severe is CVE-2026-18073?
CVE-2026-18073 has a CVSS 3.x base score of 4.4, rated medium severity. It is exploitable over local access with low attack complexity, requires low privileges and no user interaction. Impact on confidentiality is low, integrity low, and availability none.
Is CVE-2026-18073 being actively exploited?
It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 0% (1st percentile), an estimate of the probability of exploitation in the next 30 days.
What products are affected by CVE-2026-18073?
CVE-2026-18073 primarily affects Ibm I. In total, 4 product configurations (CPEs) are listed as vulnerable; see the affected-products list for the exact versions.
How do I fix CVE-2026-18073?
Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround.
When was CVE-2026-18073 published?
CVE-2026-18073 was published on 2026-09-04 and last updated on 2026-09-08.

References

Affected products (4)

More vulnerabilities in Ibm I

All CVEs affecting Ibm I →

Other CWE-78 (OS Command Injection) vulnerabilities

Browse all CWE-78 (OS Command Injection) vulnerabilities →